Response to: Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan Response

Sven Haller, Frederik Barkhof, David D. Thomas, Karl‐Olof Lövblad, Xavier Golay, Greg ZaharchukRadiology 2017

Abstract

Response to: Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan Response
BibTeX
@inproceedings{haller2017response,
  author = {Sven Haller and Frederik Barkhof and David D. Thomas and Karl‐Olof Lövblad and Xavier Golay and Greg Zaharchuk},
  title = {{Response to: Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan Response}},
  booktitle = {Radiology},
  year = {2017},
}

Loading related content...

Figure